For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a new initiative to significantly reduce, refine, and replace animal testing ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...